Literature DB >> 26076649

More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.

Garry Dolton1, Katie Tungatt1, Angharad Lloyd1, Valentina Bianchi1, Sarah M Theaker1, Andrew Trimby1, Christopher J Holland1, Marco Donia2, Andrew J Godkin1, David K Cole1, Per Thor Straten2, Mark Peakman3, Inge Marie Svane2, Andrew K Sewell1.   

Abstract

Analysis of antigen-specific T-cell populations by flow cytometry with peptide-MHC (pMHC) multimers is now commonplace. These reagents allow the tracking and phenotyping of T cells during infection, autoimmunity and cancer, and can be particularly revealing when used for monitoring therapeutic interventions. In 2009, we reviewed a number of 'tricks' that could be used to improve this powerful technology. More recent advances have demonstrated the potential benefits of using higher order multimers and of 'boosting' staining by inclusion of an antibody against the pMHC multimer. These developments now allow staining of T cells where the interaction between the pMHC and the T-cell receptor is over 20-fold weaker (K(D) > 1 mm) than could previously be achieved. Such improvements are particularly relevant when using pMHC multimers to stain anti-cancer or autoimmune T-cell populations, which tend to bear lower affinity T-cell receptors. Here, we update our previous work to include discussion of newer tricks that can produce substantially brighter staining even when using log-fold lower concentrations of pMHC multimer. We further provide a practical guide to using pMHC multimers that includes a description of several common pitfalls and how to circumvent them.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cell; T-cell receptor; peptide-MHC dextramer; peptide-MHC tetramer

Mesh:

Substances:

Year:  2015        PMID: 26076649      PMCID: PMC4552497          DOI: 10.1111/imm.12499

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.215


  53 in total

1.  Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

Authors:  Sine Reker Hadrup; Arnold H Bakker; Chengyi J Shu; Rikke S Andersen; Jerre van Veluw; Pleun Hombrink; Emilie Castermans; Per Thor Straten; Christian Blank; John B Haanen; Mirjam H Heemskerk; Ton N Schumacher
Journal:  Nat Methods       Date:  2009-06-21       Impact factor: 28.547

2.  Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.

Authors:  David K Cole; Fang Yuan; Pierre J Rizkallah; John J Miles; Emma Gostick; David A Price; George F Gao; Bent K Jakobsen; Andrew K Sewell
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

3.  CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Authors:  Ania Skowera; Richard J Ellis; Ruben Varela-Calviño; Sefina Arif; Guo Cai Huang; Cassie Van-Krinks; Anna Zaremba; Chloe Rackham; Jennifer S Allen; Timothy I M Tree; Min Zhao; Colin M Dayan; Andrew K Sewell; Wendy W Unger; Wendy Unger; Jan W Drijfhout; Ferry Ossendorp; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 4.  Tracking T cells with tetramers: new tales from new tools.

Authors:  Paul Klenerman; Vincenzo Cerundolo; P Rod Dunbar
Journal:  Nat Rev Immunol       Date:  2002-04       Impact factor: 53.106

Review 5.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

6.  Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.

Authors:  Mathew Clement; Kristin Ladell; Julia Ekeruche-Makinde; John J Miles; Emily S J Edwards; Garry Dolton; Tamsin Williams; Andrea J A Schauenburg; David K Cole; Sarah N Lauder; Awen M Gallimore; Andrew J Godkin; Scott R Burrows; David A Price; Andrew K Sewell; Linda Wooldridge
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

7.  High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses.

Authors:  Joseph J Sabatino; Jun Huang; Cheng Zhu; Brian D Evavold
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

8.  Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition.

Authors:  David K Cole; Emily S J Edwards; Katherine K Wynn; Mathew Clement; John J Miles; Kristin Ladell; Julia Ekeruche; Emma Gostick; Katherine J Adams; Ania Skowera; Mark Peakman; Linda Wooldridge; David A Price; Andrew K Sewell
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

9.  CD8 controls T cell cross-reactivity.

Authors:  Linda Wooldridge; Bruno Laugel; Julia Ekeruche; Mathew Clement; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

10.  Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers.

Authors:  Anna Lissina; Kristin Ladell; Ania Skowera; Matthew Clement; Emily Edwards; Ruth Seggewiss; Hugo A van den Berg; Emma Gostick; Kathleen Gallagher; Emma Jones; J Joseph Melenhorst; Andrew J Godkin; Mark Peakman; David A Price; Andrew K Sewell; Linda Wooldridge
Journal:  J Immunol Methods       Date:  2008-10-16       Impact factor: 2.303

View more
  47 in total

Review 1.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

2.  Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining.

Authors:  Lucas Gonzalez-Nieto; Aline Domingues; Michael Ricciardi; Martin J Gutman; Helen S Maxwell; Nuria Pedreño-Lopez; Varian Bailey; Diogo M Magnani; Mauricio A Martins
Journal:  J Vis Exp       Date:  2016-12-23       Impact factor: 1.355

3.  Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.

Authors:  Christof C Smith; Kathryn E Beckermann; Dante S Bortone; Aguirre A De Cubas; Lisa M Bixby; Samuel J Lee; Anshuman Panda; Shridar Ganesan; Gyan Bhanot; Eric M Wallen; Matthew I Milowsky; William Y Kim; W Kimryn Rathmell; Ronald Swanstrom; Joel S Parker; Jonathan S Serody; Sara R Selitsky; Benjamin G Vincent
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

4.  Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.

Authors:  Christof C Smith; Shengjie Chai; Amber R Washington; Samuel J Lee; Elisa Landoni; Kevin Field; Jason Garness; Lisa M Bixby; Sara R Selitsky; Joel S Parker; Barbara Savoldo; Jonathan S Serody; Benjamin G Vincent
Journal:  Cancer Immunol Res       Date:  2019-09-12       Impact factor: 11.151

5.  T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette-Guérin Vaccination.

Authors:  Erik D Layton; Soumik Barman; Damien B Wilburn; Krystle K Q Yu; Malisa T Smith; John D Altman; Thomas J Scriba; Nabil Tahiri; Adriaan J Minnaard; Mario Roederer; Robert A Seder; Patricia A Darrah; Chetan Seshadri
Journal:  J Immunol       Date:  2021-02-03       Impact factor: 5.422

Review 6.  An overview of immunoinformatics approaches and databases linking T cell receptor repertoires to their antigen specificity.

Authors:  Ivan V Zvyagin; Vasily O Tsvetkov; Dmitry M Chudakov; Mikhail Shugay
Journal:  Immunogenetics       Date:  2019-11-18       Impact factor: 2.846

7.  GPU-Accelerated Discovery of Pathogen-Derived Molecular Mimics of a T-Cell Insulin Epitope.

Authors:  Thomas Whalley; Garry Dolton; Paul E Brown; Aaron Wall; Linda Wooldridge; Hugo van den Berg; Anna Fuller; Jade R Hopkins; Michael D Crowther; Meriem Attaf; Robin R Knight; David K Cole; Mark Peakman; Andrew K Sewell; Barbara Szomolay
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

8.  Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.

Authors:  Amanda L Wooster; Trevor S Anderson; Devin B Lowe
Journal:  J Immunol Methods       Date:  2018-10-19       Impact factor: 2.303

Review 9.  HLA variation and disease.

Authors:  Calliope A Dendrou; Jan Petersen; Jamie Rossjohn; Lars Fugger
Journal:  Nat Rev Immunol       Date:  2018-01-02       Impact factor: 53.106

10.  Assay and Isolation of Single Proliferating CD4+ Lymphocytes Using an Automated Microraft Array Platform.

Authors:  Cody A LaBelle; Raymond J Zhang; Paul M Armistead; Nancy L Allbritton
Journal:  IEEE Trans Biomed Eng       Date:  2019-11-26       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.